Company / Accounts Receivable
Ceribell, Inc. Accounts Receivable History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$15.1M
FY2025
5-year range
$8.0M / $15.1M
FY2023-FY2025
Trend
+38.4%
vs FY2024
Sector context
#131 of 137
Health Care
What the data says
Among 137 Health Care companies, Ceribell, Inc. is in the bottom 4% for accounts receivable. Improved from $8M to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2025.
Improved from $8M to $15M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 137This company $15.1M Sector average $1.3B
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2025, accounts receivable increased 38.4% year-over-year.
- Ranks #131 out of 137 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.1M | +38.4% |
| FY2024 | $10.9M | +36.7% |
| FY2023 | $8.0M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026